目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Product
1.2.3. Route of Administration
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for Primary Interviews in North America
1.4.5.2. Data for Primary Interviews in Europe
1.4.5.3. Data for Primary Interviews in Asia Pacific
1.4.5.4. Data for Primary Interviews in Latin America
1.4.5.5. Data for Primary Interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Drug class outlook
2.2.2. Product outlook
2.2.3. Rout of administration outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Asthma Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidence of asthma
3.2.1.2. Emergence of novel biologics
3.2.1.3. Rising awareness programs
3.2.2. Market restraint analysis
3.2.2.1. Patent expiration of branded drugs
3.2.2.2. Regulatory challenges
3.3. Asthma Therapeutics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Asthma Therapeutics Market: Drug Class Estimates & Trend Analysis
4.1. Drug Class Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Asthma Therapeutics Market by Drug Class Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Anti- inflammatory
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.2. Bronchodilators
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.3. Combination Therapy
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Asthma Therapeutics Market: Product Estimates & Trend Analysis
5.1. Product Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Asthma Therapeutics Market by Product Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Inhalers
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.1.2. Dry Powder
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.1.3. Metered Dose
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.1.4. Soft Mist
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.2. Nebulizers
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Asthma Therapeutics Market: Route of Administration Estimates & Tred Analysis
6.1. Route of Administration Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Asthma Therapeutics Market by Route of Administration Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Oral
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
6.4.2. Inhaled
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
6.4.3. Others
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Asthma Therapeutics Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
7.6. Europe
7.6.1. Germany
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.2. UK
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
7.7.4. South Korea
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
7.7.5. Australia
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Teva Pharmaceutical Industries Ltd
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. GSK plc
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Merck & Co., Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. F. Hoffmann-La Roche Ltd
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. AstraZeneca
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Boehringer Ingelheim International GmbH
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Sanofi
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Koninklijke Philips N.V.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. BD
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Covis Pharma
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America asthma therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 3 North America asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 4 North America asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 5 North America asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 6 U.S. asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 7 U.S. asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 8 U.S. asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 9 Canada asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 10 Canada asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 11 Canada asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 12 Europe asthma therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 13 Europe asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 14 Europe asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 15 Europe asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 16 Germany asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 17 Germany asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 18 Germany asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 19 UK asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 20 UK asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 21 UK asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 22 France asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 23 France asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 24 France asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 25 Italy asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 26 Italy asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 27 Italy asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 28 Spain asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 29 Spain asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 30 Spain asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 31 Denmark asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 32 Denmark asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 33 Denmark asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 34 Sweden asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 35 Sweden asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 36 Sweden asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 37 Norway asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 38 Norway asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 39 Norway asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 40 Asia Pacific asthma therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 41 Asia Pacific asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 42 Asia Pacific asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 43 Asia Pacific asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 44 China asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 45 China asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 46 China asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 47 Japan asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 48 Japan asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 49 Japan asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 50 India asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 51 India asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 52 India asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 53 South Korea asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 54 South Korea asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 55 South Korea asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 56 Australia asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 57 Australia asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 58 Australia asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 59 Thailand asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 60 Thailand asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 61 Thailand asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 62 Latin America asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 63 Latin America asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 64 Latin America asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 65 Brazil asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 66 Brazil asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 67 Brazil asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 68 Mexico asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 69 Mexico asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 70 Mexico asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 71 Argentina asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 72 Argentina asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 73 Argentina asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 74 MEA asthma therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 75 MEA asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 76 MEA asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 77 MEA asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 78 South Africa asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 79 South Africa asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 80 South Africa asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 81 Saudi Arabia asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 82 Saudi Arabia asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 83 Saudi Arabia asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 84 UAE asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 85 UAE asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 86 UAE asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)
Table 87 Kuwait asthma therapeutics market, by drug class, 2018 - 2030 (USD Billion)
Table 88 Kuwait asthma therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 89 Kuwait asthma therapeutics market, by route of administration, 2018 - 2030 (USD Billion)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary Interviews in North America
Fig. 5 Primary Interviews in Europe
Fig. 6 Primary Interviews in APAC
Fig. 7 Primary Interviews in Latin America
Fig. 8 Primary Interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Asthma therapeutics market: market outlook
Fig. 14 Asthma therapeutics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Asthma therapeutics market driver impact
Fig. 20 Asthma therapeutics market restraint impact
Fig. 21 Asthma therapeutics market strategic initiatives analysis
Fig. 22 Asthma therapeutics market: Drug class movement analysis
Fig. 23 Asthma therapeutics market: Drug class outlook and key takeaways
Fig. 24 Anti-inflammatory market estimates and forecast, 2018 - 2030
Fig. 25 Bronchodilators inhalers market estimates and forecast, 2018 - 2030
Fig. 26 Combination therapy inhalers market estimates and forecast, 2018 - 2030
Fig. 27 Asthma therapeutics market: Product movement analysis
Fig. 28 Asthma therapeutics market: Product outlook and key takeaways
Fig. 29 Inhalers market estimates and forecast, 2018 - 2030
Fig. 30 Dry powder inhalers market estimates and forecast, 2018 - 2030
Fig. 31 Metered dose inhalers market estimates and forecast, 2018 - 2030
Fig. 32 Soft mist inhalers market estimates and forecast, 2018 - 2030
Fig. 33 Nebulizers market estimates and forecast, 2018 - 2030
Fig. 34 Asthma therapeutics market: Route of administration movement analysis
Fig. 35 Asthma therapeutics market: Route of administration outlook and key takeaways
Fig. 36 Oral market estimates and forecasts, 2018 - 2030
Fig. 37 Inhaled market estimates and forecasts,2018 - 2030
Fig. 38 Others market estimates and forecasts, 2018 - 2030
Fig. 39 Global asthma therapeutics market: Regional movement analysis
Fig. 40 Global asthma therapeutics market: Regional outlook and key takeaways
Fig. 41 Global asthma therapeutics market shares and leading players
Fig. 42 North America market share and leading players
Fig. 43 Europe market share and leading players
Fig. 44 Asia Pacific market share and leading players
Fig. 45 Latin America market share and leading players
Fig. 46 Middle East & Africa market share and leading players
Fig. 47 North America: SWOT
Fig. 48 Europe SWOT
Fig. 49 Asia Pacific SWOT
Fig. 50 Latin America SWOT
Fig. 51 MEA SWOT
Fig. 52 North America, by country
Fig. 53 North America
Fig. 54 North America market estimates and forecasts, 2018 - 2030
Fig. 55 U.S. key country dynamics
Fig. 56 U.S. market estimates and forecasts, 2018 - 2030
Fig. 57 Canada key country dynamics
Fig. 58 Canada market estimates and forecasts, 2018 - 2030
Fig. 59 Europe
Fig. 60 Europe market estimates and forecasts, 2018 - 2030
Fig. 61 UK key country dynamics
Fig. 62 UK market estimates and forecasts, 2018 - 2030
Fig. 63 Germany key country dynamics
Fig. 64 Germany market estimates and forecasts, 2018 - 2030
Fig. 65 France key country dynamics
Fig. 66 France market estimates and forecasts, 2018 - 2030
Fig. 67 Italy key country dynamics
Fig. 68 Italy market estimates and forecasts, 2018 - 2030
Fig. 69 Spain key country dynamics
Fig. 70 Spain market estimates and forecasts, 2018 - 2030
Fig. 71 Denmark key country dynamics
Fig. 72 Denmark market estimates and forecasts, 2018 - 2030
Fig. 73 Sweden key country dynamics
Fig. 74 Sweden market estimates and forecasts, 2018 - 2030
Fig. 75 Norway key country dynamics
Fig. 76 Norway market estimates and forecasts, 2018 - 2030
Fig. 77 Asia Pacific
Fig. 78 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 79 China key country dynamics
Fig. 80 China market estimates and forecasts, 2018 - 2030
Fig. 81 Japan key country dynamics
Fig. 82 Japan market estimates and forecasts, 2018 - 2030
Fig. 83 India key country dynamics
Fig. 84 India market estimates and forecasts, 2018 - 2030
Fig. 85 Thailand key country dynamics
Fig. 86 Thailand market estimates and forecasts, 2018 - 2030
Fig. 87 South Korea key country dynamics
Fig. 88 South Korea market estimates and forecasts, 2018 - 2030
Fig. 89 Australia key country dynamics
Fig. 90 Australia market estimates and forecasts, 2018 - 2030
Fig. 91 Latin America
Fig. 92 Latin America market estimates and forecasts, 2018 - 2030
Fig. 93 Brazil key country dynamics
Fig. 94 Brazil market estimates and forecasts, 2018 - 2030
Fig. 95 Mexico key country dynamics
Fig. 96 Mexico market estimates and forecasts, 2018 - 2030
Fig. 97 Argentina key country dynamics
Fig. 98 Argentina market estimates and forecasts, 2018 - 2030
Fig. 99 Middle East and Africa
Fig. 100 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 101 South Africa key country dynamics
Fig. 102 South Africa market estimates and forecasts, 2018 - 2030
Fig. 103 Saudi Arabia key country dynamics
Fig. 104 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 105 UAE key country dynamics
Fig. 106 UAE market estimates and forecasts, 2018 - 2030
Fig. 107 Kuwait key country dynamics
Fig. 108 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 109 Market share of key market players - Asthma therapeutics market